Vycor Medical (VYCO) Long-Term Deferred Tax (2020 - 2025)

Vycor Medical (VYCO) has 8 years of Long-Term Deferred Tax data on file, last reported at $58000.0 in Q4 2025.

• Quarterly Long-Term Deferred Tax fell 98.61% year-over-year to $58000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $58000.0 (down 98.61% YoY) and the FY2025 annual result came in at $58000.0, down 98.61% from the prior year.
• Long-Term Deferred Tax retreated to $58000.0 in Q4 2025 per VYCO's latest filing, from $4.2 million in the prior quarter.
• Across five years, Long-Term Deferred Tax topped out at $4.2 million in Q4 2024 and bottomed at $58000.0 in Q4 2025.
• The 5-year median for Long-Term Deferred Tax is $509000.0 (2021), against an average of $1.9 million.
• The widest annual swing landed in 2023, when Long-Term Deferred Tax surged 740.24%; it then tumbled 98.61% in 2025.
• Tracing VYCO's Long-Term Deferred Tax over 5 years: stood at $509000.0 in 2021, then retreated by 2.36% to $497000.0 in 2022, then surged by 740.24% to $4.2 million in 2023, then gained by 0.07% to $4.2 million in 2024, then plunged by 98.61% to $58000.0 in 2025.
• Per Business Quant, the three latest VYCO Long-Term Deferred Tax figures stand at $58000.0 (Q4 2025), $4.2 million (Q4 2024), and $4.2 million (Q4 2023).

Peer Comparison